These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9809889)

  • 1. A perspective on the regulation of the evaluation of new antithrombotic drugs.
    Califf RM
    Am J Cardiol; 1998 Oct; 82(8B):25P-35P. PubMed ID: 9809889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substantial evidence of effect.
    Gould AL
    J Biopharm Stat; 2002 Feb; 12(1):53-77. PubMed ID: 12146720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rules of evidence and clinical recommendations on the use of antithrombotic agents.
    Sackett DL
    Chest; 1989 Feb; 95(2 Suppl):2S-4S. PubMed ID: 2914516
    [No Abstract]   [Full Text] [Related]  

  • 5. Current trends in antithrombotic drug and device development.
    Fareed J
    Semin Thromb Hemost; 1996; 22 Suppl 1():3-8. PubMed ID: 8807721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of putative placebo in active control trials: two applications in a regulatory setting.
    Durrleman S; Chaikin P
    Stat Med; 2003 Mar; 22(6):941-52. PubMed ID: 12627411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating equivalence and noninferiority trials.
    Dasgupta A; Lawson KA; Wilson JP
    Am J Health Syst Pharm; 2010 Aug; 67(16):1337-43. PubMed ID: 20689122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing the technology of clinical trials and the trials model to evaluate newly developed, targeted antidepressants.
    Katz MM; Halbreich UM; Bowden CL; Frazer A; Pinder RM; Rush AJ; Wheatley DP; Lebowitz BD
    Neuropsychopharmacology; 2002 Sep; 27(3):319-28. PubMed ID: 12225690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equivalence and noninferiority testing in regression models and repeated-measures designs.
    Mascha EJ; Sessler DI
    Anesth Analg; 2011 Mar; 112(3):678-87. PubMed ID: 21304155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo or active control trials of antipsychotic drugs?
    Fleischhacker WW; Czobor P; Hummer M; Kemmler G; Kohnen R; Volavka J
    Arch Gen Psychiatry; 2003 May; 60(5):458-64. PubMed ID: 12742866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methodological and statistical aspects of equivalence and non inferiority trials].
    Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P
    Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery.
    Dörffler-Melly J; Büller HR; Koopman MM; Prins MH
    Cochrane Database Syst Rev; 2003; (4):CD000536. PubMed ID: 14583924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General design issues in efficacy, equivalency and superiority trials.
    Fleiss JL
    J Periodontal Res; 1992 Jul; 27(4 Pt 2):306-13; discussion 323-7. PubMed ID: 1507018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When clinical trials make history: demonstrating efficacy of new antiepileptic drugs as monotherapy.
    Perucca E
    Epilepsia; 2010 Oct; 51(10):1933-5. PubMed ID: 20491875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The arterial thrombotic process and emerging drugs for its control.
    Maraganore JM
    Tex Heart Inst J; 1993; 20(1):43-7. PubMed ID: 8508063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing clinical trials to assess antiepileptic drugs as monotherapy : difficulties and solutions.
    Perucca E
    CNS Drugs; 2008; 22(11):917-38. PubMed ID: 18840033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equivalence concepts in clinical trials.
    Steinijans VW; Neuhäuser M; Bretz F
    Eur J Drug Metab Pharmacokinet; 2000; 25(1):38-40. PubMed ID: 11032089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based medicine: the design and interpretation of noninferiority clinical trials in veterinary medicine.
    Freise KJ; Lin TL; Fan TM; Recta V; Clark TP
    J Vet Intern Med; 2013; 27(6):1305-17. PubMed ID: 24128266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic stewardship: a multidisciplinary team approach towards improving antithrombotic therapy outcomes during and after hospitalisation: a study protocol.
    Dreijer AR; Kruip MJ; Diepstraten J; Polinder S; Brouwer R; Leebeek FW; Vulto AG; van den Bemt PM
    BMJ Open; 2016 Dec; 6(12):e011537. PubMed ID: 27998897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Through the looking glass: understanding non-inferiority.
    Schumi J; Wittes JT
    Trials; 2011 May; 12():106. PubMed ID: 21539749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.